NanoSphere Health Sciences (CSE:NSHS) (OTC: NSHSF) (‘NanoSphere or ‘the Company’) parent company of cannabis brand Evolve Formulas, in partnership with Vertical™, the largest fully integrated company in the legal medical cannabis industry, will formally unveil the Evolve Formulas line for the California market at the Hall of Flowers trade show on April 30.
The Hall of Flowers event is a licensed, industry-only, highly curated B2B trade show specifically designed to facilitate the trade of premium licensed cannabis products, including flowers, concentrate, edible, topical, and accessory categories.
NanoSphere and its California production and distribution partner The Vertical Companies (Vertical) are inviting all dispensaries and cannabis distributors to join us at the Vertical booth on April 30th for a demonstration of the new product, sold under the Evolve Formulas brand.
Evolve Formulas is the provider of the world’s first and only scientifically-proven nanoparticle delivery system for cannabis. Evolve’s pioneering product, Transdermal NanoSerum™, is a fast-acting, ultra-strength transdermal pain formula with nano-encapsulated cannabis, terpenes and cannabis extracts. ”Through our patented formula, we are able to break up cannabinoids into stable, phospholipid encapsulated nano-sized particles that pass readily through the skin to the bloodstream,” explains NanoSphere CEO Robert Sutton. “This ability to deliver our proprietary cannabinoid pain formula directly to the source of pain is what makes our transdermal NanoSerum™ more effective than topical products.”
This Evolve Formulas product was approved for sale in California on April 8, 2019 and the first shipment sold to the Shangri La Care Centre in Ojai, California, sold out in just five days. “We have been test marketing our product in California for only a few weeks, and at a limited number of stores, so we’re very gratified to see the great response to this new product,” said NanoSphere Director of Sales Richard Pipp. “We now look forward to expanding our product launch throughout California.”
NanoSphere has also signed sales and distribution agreements in Colorado, Oregon, Canada and Mexico, and is negotiating further license agreements in several countries and US states. Distribution inquiries can be sent to David Sutton, email@example.com, or Richard Pipp, firstname.lastname@example.org.
On behalf of the Board
David Sutton, President and COO
Victor Goncalves, Executive Vice President
NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About Evolve Formulas
Evolve Formulas is the provider of the world’s first and only scientifically proven nanoparticle delivery system in cannabis. Evolve’s pioneering product, Transdermal NanoSerum™, is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts. For more information on Evolve Formulas, visithttps://www.evolveformulas.com/. Follow us on Facebook, Instagram and Twitter.
Vertical is one of the first and largest vertically integrated companies in the legal medical cannabis industry. We have operations in CA and AZ, combined with strategic partnerships in CO, MI, OR, and other markets which position us well to take advantage of the legalization and normalization of cannabis globally. Vertical is led by an executive team of entrepreneurs and business leaders from the alcohol beverage, agriculture, CPG, distribution, entertainment, food, healthcare and medical industries. Vertical’s operations include planning, permitting, development and operation of cultivation, extraction, manufacturing, distribution and brands. We have world class capabilities in product development, co-packing, branding, marketing, distribution, education, and legal compliance. Vertical does Everything Pertaining to Green.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements in this news release which are not purely historical are forward looking statements, including without limitation any statements concerning the Company’s intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without limitation those relating to the Company’s future operations and business prospects, are based on assumptions none of which can be assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from those indicated in the forward looking statements. Without limitation, these include assumptions, risks and uncertainties inherent in completing sub-licensing arrangements in the United States, Canada and abroad, product demand, production, competition and government regulation of the Cannabis industry, any and all of which may have an adverse effect on the Company’s expansion plans, sales, revenues and its financial results and condition. Readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result of new information, future events or otherwise.
Kate Wells NanoSphere Health Sciences (303) 324-7358 email@example.com